Tirzepatide works through a fundamentally different mechanism, targeting two receptors instead of one, and the clinical data shows it consistently outperforms semaglutide for both weight loss and metabolic improvement
Early animal and laboratory studies have explored its potential role in tissue repair and inflammation, but its cardiovascular effects and risks in humans remain unknown
Every order is labelled for laboratory research use only, and it is the purchaser's responsibility to ensure their intended research use complies with all applicable UK laws and regulations
Indications for use: Deficiency of Vitamin B12, B6, and folic acid
Peptides are short chains of amino acids that can selectively target certain cells and pathways to fine-tune immune responses and decrease local inflammation
Dose typically starts at 0.25 mg and gradually increases to 2.4 mg weekly, or the highest amount the patient can tolerate comfortably